These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1638838)

  • 1. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors.
    Caluser C; Macapinlac H; Healey J; Ghavimi F; Meyers P; Wollner N; Kalaigian J; Kostakoglu L; Abdel-Dayem HM; Yeh SD
    Clin Nucl Med; 1992 Jul; 17(7):565-72. PubMed ID: 1638838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours.
    Ozcan Z; Burak Z; Erinç R; Dirlik A; Başdemir G; Sabah D; Ozkiliç H
    Nucl Med Commun; 2001 Jun; 22(6):679-83. PubMed ID: 11403180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
    Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors].
    Tsuda T; Kubota M; Yoshida S; Shibata M; Wakabayashi J; Obata H; Matsuyama T; Usui M; Ishii S
    Kaku Igaku; 1994 Dec; 31(12):1477-94. PubMed ID: 7861647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.
    Caluser CI; Abdel-Dayem HM; Macapinlac HA; Scott A; Healey JH; Huvos A; Kalaigian H; Yeh SD; Larson SM
    Eur J Nucl Med; 1994 Nov; 21(11):1198-205. PubMed ID: 7859771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thallium-201 uptake and Tc-99m red blood cell accumulation in hemangioma.
    Verdú J; Martínez A; Antón MA; Muñoz JM; Riera M; Jover R; Caballero O
    Clin Nucl Med; 2005 Jan; 30(1):25-6. PubMed ID: 15604963
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Yokoe K; Kawaguchi Y; Toyama Y; Satoh K; Ohkawa M
    Ann Nucl Med; 2004 May; 18(3):235-41. PubMed ID: 15233285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99m)Tc-MDP uptake in soft-tissue osteosarcoma in a dog.
    Lass P; Krzemiński M; Teodorczyk J
    Nucl Med Rev Cent East Eur; 2004; 7(2):189. PubMed ID: 15968610
    [No Abstract]   [Full Text] [Related]  

  • 9. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
    Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
    Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tl-201 uptake in bone and soft tissue involvement of sarcoidosis.
    Degirmenci B; Mavi A; Ozkal S; Itil O; Havitcioglu H; Ozaksoy D; Yilmaz M; Kaya GC
    Clin Nucl Med; 2001 Jun; 26(6):499-501. PubMed ID: 11353294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tl-201 uptake in brown tumors of hyperparathyroidism.
    Durak H; Aras T; Sungur C; Erbengi G; Bekdik CF
    Clin Nucl Med; 1991 Dec; 16(12):931-5. PubMed ID: 1769175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
    Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
    J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of nuclear medicine in primary bone and soft tissue tumors.
    Abdel-Dayem HM
    Semin Nucl Med; 1997 Oct; 27(4):355-63. PubMed ID: 9364645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better visualization of retinoblastoma metastases with Tc-99m sestamibi versus Tl-201.
    Aktolun C; Bayhan H; Ozturk E
    Clin Nucl Med; 1995 May; 20(5):446-8. PubMed ID: 7628151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tl-201 uptake in recurrent pigmented villonodular synovitis. Correlation with three-phase bone imaging.
    Caluser C; Healey J; Macapinlac H; Kostakoglu L; Abdel-Dayem HM; Larson SM; Yeh SD
    Clin Nucl Med; 1992 Sep; 17(9):751-3. PubMed ID: 1395357
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual Concentration of Tc-99m methylendiphosphonate in Rhabdomyosarcoma.
    Franco A; Henderson PR; McDonough CH
    J Radiol Case Rep; 2012 Sep; 6(9):29-34. PubMed ID: 23378886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.